Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ANZUWNASDAQ:ATAKWNASDAQ:DRTSWNASDAQ:PAVMZ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANZUWAnzu Special Acquisition Corp I$0.06+8.5%$0.04$0.00▼$0.15N/AN/A32,101 shs171 shsATAKWAurora Technology Acquisition$0.01-8.0%$0.01$0.01▼$0.04N/AN/A85,679 shs45,958 shsDRTSWAlpha Tau Medical$0.22+2.4%$0.22$0.09▼$0.50N/AN/A20,455 shs100 shsPAVMZPAVmed$0.00-40.0%$0.00$0.00▼$0.06N/AN/A16,598 shs258,763 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANZUWAnzu Special Acquisition Corp I0.00%+0.46%+56.76%+82.30%+30.58%ATAKWAurora Technology Acquisition0.00%-1.32%-1.32%-23.20%-51.31%DRTSWAlpha Tau Medical-1.87%-15.97%+16.67%-22.22%-12.50%PAVMZPAVmed0.00%0.00%0.00%-82.56%-97.76%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/AN/AN/APAVMZPAVmedN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANZUWAnzu Special Acquisition Corp I 0.00N/AN/AN/AATAKWAurora Technology Acquisition 0.00N/AN/AN/ADRTSWAlpha Tau Medical 0.00N/AN/AN/APAVMZPAVmed 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/APAVMZPAVmed$3.00MN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANZUWAnzu Special Acquisition Corp IN/AN/A0.00∞N/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/A0.00∞N/AN/AN/AN/AN/APAVMZPAVmedN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/APAVMZPAVmedN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANZUWAnzu Special Acquisition Corp IN/AATAKWAurora Technology AcquisitionN/ADRTSWAlpha Tau MedicalN/APAVMZPAVmedN/AInsider OwnershipCompanyInsider OwnershipANZUWAnzu Special Acquisition Corp IN/AATAKWAurora Technology AcquisitionN/ADRTSWAlpha Tau MedicalN/APAVMZPAVmedN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANZUWAnzu Special Acquisition Corp I2N/AN/ANot OptionableATAKWAurora Technology AcquisitionN/AN/AN/ANot OptionableDRTSWAlpha Tau Medical80N/AN/ANot OptionablePAVMZPAVmed90N/AN/ANot OptionablePAVMZ, DRTSW, ANZUW, and ATAKW HeadlinesRecent News About These CompaniesPAVmed Reports Q1 2025 Financial Results and UpdatesMay 15, 2025 | tipranks.comPAVmed Reports Strong Q4 Results and Strategic ProgressMarch 26, 2025 | tipranks.comPAVmed Reports Record Revenue and Strategic RestructuringNovember 14, 2024 | tipranks.comPAVM Stock Earnings: PAVmed Beats EPS, Misses Revenue for Q1 2024May 14, 2024 | investorplace.comPAVM Stock Earnings: PAVmed Beats EPS, Misses Revenue for Q4 2023March 27, 2024 | investorplace.comMedia Sentiment Over TimePAVMZ, DRTSW, ANZUW, and ATAKW Company DescriptionsAnzu Special Acquisition Corp I NASDAQ:ANZUW$0.06 +0.01 (+8.53%) As of 05/30/2025Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Aurora Technology Acquisition NASDAQ:ATAKW$0.01 0.00 (-8.02%) As of 05/30/2025Aurora Technology Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to focus on businesses in the technology companies, including artificial intelligence, blockchain, quantum computing, and electric vehicles in Asia and North America. The company was incorporated in 2021 and is based in San Francisco, California.Alpha Tau Medical NASDAQ:DRTSW$0.22 +0.01 (+2.38%) As of 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.PAVmed NASDAQ:PAVMZ$0.0009 0.00 (-40.00%) As of 04/30/2025PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Reasons Amazon Could Be the Best Tech Performer in June Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next Applied Digital: CoreWeave’s AI Deal Lights a $7 Billion Fuse Qualcomm: A Technical Deep-Dive Confirms the Worst Rocket Lab Expands Into Payloads: Should You Be Paying Attention? Steel Dynamics Shares Climb After Tariff Announcement Palantir Soars on Government Deals as Valuation Debate Lingers Broadcom Earnings Preview: AVGO Stock Near Record Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
